http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013102263-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2011-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013102263-A |
| titleOfInvention | GEL DOSAGE FORMS FOR LOCAL USE OF 1-AMINOalkylcyclohexane derivatives |
| abstract | 1. A pharmaceutical composition for topical application to the skin of a patient, comprising. neramexane or a pharmaceutically acceptable salt thereof; and b. at least one gelling agent, wherein said gelling agent is a polymer containing a neutral or positively charged polymer backbone. 2. The pharmaceutical composition according to claim 1, wherein said at least one gelling agent is selected from chitosan, xanthan gum, cellulose and hydroxyalkyl cellulose, in particular hydroxyethyl cellulose or hydroxypropyl cellulose. The pharmaceutical composition according to claim 1, comprising a mixture of at least two different gelling agents, comprising a) at least one polymer containing a neutral polymer backbone; and b) at least one polymer containing a positively charged polymer backbone. The pharmaceutical composition of claim 3, wherein said at least one polymer containing a neutral polymer backbone is cellulose or hydroxyalkyl cellulose, and wherein said at least one polymer containing a positively charged polymer backbone is chitosan. 5. The pharmaceutical composition according to claim 3, wherein said at least one polymer containing a neutral polymer main chain and said at least one polymer containing a positively charged polymer main chain are present in said mixture in a ratio in the range of 1 approximately 0.04 and in the range 1 approximately 25, in particular in a ratio in the range 1 approximately 0.1 and |
| priorityDate | 2010-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.